POTENTIATE trial ongoing in patients with oncogene amplified cancers, with initial proof of concept data expected in the second ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States Department of Computational and Systems Biology, University of Pittsburgh, 3420 ...

(Sharecast News) - Uniphar reported a strong 2024 on Tuesday, recording an 8.5% increase in revenue to €2.77bn and a 9.6% rise in gross profit to €427.6m. The AIM-traded firm said adjusted ...

Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States ...

This cover highlights the article Multimodal mechanisms of human centriole engagement and disengagement by Kei K. Ito, Shoji Hata, Daiju Kitagawa and colleagues. The cover image depicts the centriole ...

Colchicine, doxorubicin (adriamycin), mitoxantrone, and verapamil were purchased from Sigma Aldrich Trading Co. (Shanghai, China). All of the drugs were dissolved in 100% DMSO to produce a 10 mM stock ...

Because of these effects, understanding the out-of-pocket costs for SGLT-2 inhibitors is essential. However, estimates for out-of-pocket costs are limited with no nationally representative or ...